Synthesis and Antitumor Activity of Stearate-g-dextran Micelles for Intracellular Doxorubicin Delivery
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Stearate-g-dextran (Dex-SA) was synthesized via an esterification reaction between the carboxyl group of stearic acid (SA) and hydroxyl group of dextran (Dex). Dex-SA could self-assemble to form nanoscaled micelles in aqueous medium. The critical micelle concentration (CMC) depended on the molecular weight of Dex and the graft ratio of SA, which ranged from 0.01 to 0.08 mg mL(-1). Using doxorubicin (DOX) as a model drug, the drug encapsulation efficiency (EE%) using Dex-SA with 10 kDa molecular weight of Dex and 6.33% graft ratio of SA could reach up to 84%. In vitro DOX release from DOX-loaded Dex-SA micelles (Dex-SA/DOX) could be prolonged to 48 h, and adjusted by a different molecular weight of Dex, the graft ratio of SA, or the drug-loading content. Tumor cellular uptake test indicated that Dex-SA micelles had excellent internalization ability, which could deliver DOX into tumor cells. In vitro cytotoxicity tests demonstrated the Dex-SA/DOX micelles could maintain the cytotoxicity of commercial doxorubicin injection against drug-sensitive tumor cells. Moreover, Dex-SA/DOX micelles presented reversal activity against DOX-resistant cells. In vivo antitumor activity results showed that Dex-SA/DOX micelles treatments effectively suppressed the tumor growth and reduced the toxicity against animal body compared with commercial doxorubicin injection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Factors affecting the clearance and biodistribution of polymeric nanoparticles
Alexis, F., Pridgen, E., Molnar, L. K., & Farokhzad, O. C. (2008) · Molecular Pharmaceutics · doi:10.1021/mp800051m · Cited by 3,699 · cited 1×
“The drug delivery systems without surface charge could reduce plasma protein adsorption and increase the rate of nonspecific cellular uptake.(18) The anthracycline anticancer drug, doxorubicin (DOX), is widely used in chemotherapy for various tumors, including hematological malignancies, many types of carcinoma, and s…”
BackgroundAmphiphilic block copolymers for drug delivery
Adams, M. L., Lavasanifar, A., & Kwon, G. S. (2003) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10397 · Cited by 1,078 · cited 1×
“loendothelial system (RES) uptake, which helps to increase blood residence time.(3)”
BackgroundCore-cross-linked polymeric micelles as paclitaxel carriers
Shuai, X., Merdan, T., Schaper, A. K., Xi, F., & Kissel, T. (2004) · Bioconjugate Chemistry · doi:10.1021/bc034113u · Cited by 333 · cited 1×
“EL which easily causes hypersensitivity reactions.(4) 10”
Cited by
Hydrogels for Protein Delivery
Vermonden, T., Censi, R., & Hennink, W. E. (2012) · Chemical Reviews · doi:10.1021/cr200157d · Cited by 1,091
Multifunctional polymeric micelles for delivery of drugs and siRNA
Jhaveri, A. M., & Torchilin, V. P. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00077 · Cited by 466
Recent advances in dextran-based drug delivery systems: From fabrication strategies to applications
Hu, Q., Lu, Y., & Luo, Y. (2021) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2021.117999 · Cited by 315
Liu, Q., Yin, B., Yang, T., Yang, Y., Shen, Z., Yao, P., & Li, F. (2013) · Journal of the American Chemical Society · doi:10.1021/ja3104268 · Cited by 297
Ke, X., Ng, V. W. L., Ono, R. J., Chan, J. M. W., Krishnamurthy, S., Wang, Y., Hedrick, J. L., & Yang, Y. Y. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.06.061 · Cited by 146
Zhang, Y., Li, P., Pan, H., Liu, L., Ji, M., Sheng, N., Wang, C., Cai, L., & Ma, Y. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.01.023 · Cited by 56
Metadata
- Authors
- Du, Y.-Z., Weng, Q., Yuan, H., & Hu, F.-Q.
- Venue
- ACS Nano
- Publisher
- American Chemical Society (ACS)
- Published
- 2010-10-12
- Volume
- 4
- Issue
- 11
- Pages
- 6894-6902
- ISSN
- 1936-0851 (ISSN-L)
- 1936-086X
- OpenAlex
- W2036370359
- Cited by
- 175
- References
- 3
- FWCI
- 5.00
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.